%0 Journal Article
%T Tumor cells impair immunological synapse formation via central nervous system-enriched metabolite.
%A Li Y
%A Huang M
%A Wang M
%A Wang Y
%A Deng P
%A Li C
%A Huang J
%A Chen H
%A Wei Z
%A Ouyang Q
%A Zhao J
%A Lu Y
%A Su S
%J Cancer Cell
%V 42
%N 6
%D 2024 Jun 10
%M 38821061
%F 38.585
%R 10.1016/j.ccell.2024.05.006
%X Tumors employ various strategies to evade immune surveillance. Central nervous system (CNS) has multiple features to restrain immune response. Whether tumors and CNS share similar programs of immunosuppression is elusive. Here, we analyze multi-omics data of tumors from HER2+ breast cancer patients receiving trastuzumab and anti-PD-L1 antibody and find that CNS-enriched N-acetyltransferase 8-like (NAT8L) and its metabolite N-acetylaspartate (NAA) are overexpressed in resistant tumors. In CNS, NAA is released during brain inflammation. NAT8L attenuates brain inflammation and impairs anti-tumor immunity by inhibiting cytotoxicity of natural killer (NK) cells and CD8+ T cells via NAA. NAA disrupts the formation of immunological synapse by promoting PCAF-induced acetylation of lamin A-K542, which inhibits the integration between lamin A and SUN2 and impairs polarization of lytic granules. We uncover that tumor cells mimic the anti-inflammatory mechanism of CNS to evade anti-tumor immunity and NAT8L is a potential target to enhance efficacy of anti-cancer agents.